The ‘most favored nation’ policy proposed by the administration could have significant consequences for patient access and healthcare competition. This policy would link drug prices in the U.S. to those in countries with single-payer systems, like Canada and European nations. The concern lies in the fact that these countries often set drug prices through government […]